SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 154 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $935,000 | -18.9% | 91,200 | +3.3% | 0.02% | -51.3% |
Q2 2016 | $1,153,000 | +137.2% | 88,300 | +99.9% | 0.04% | +178.6% |
Q1 2016 | $486,000 | -36.0% | 44,170 | -42.9% | 0.01% | -30.0% |
Q2 2015 | $759,000 | +20.7% | 77,300 | +8.9% | 0.02% | +17.6% |
Q1 2015 | $629,000 | +208.3% | 71,000 | +139.9% | 0.02% | +112.5% |
Q3 2014 | $204,000 | – | 29,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |